HIGHLIGHTS
- who: Aleksandra Gentry-Maharaj PhD from the arms of the multicenter randomized controlled trial, United Kingdom have published the paper: Serum HE4 and diagnosis of ovarian cancer in postmenopausal women with adnexal masses, in the Journal: (JOURNAL)
- what: The study was conducted to assess whether inclusion of human epididymis 4 (HE4) improves the performance of serum CA125 and transvaginal ultrasound in the differential diagnosis of ovarian cancer in postmenopausal women with adnexal masses. It was not possible using this study design to evaluate the performance of HE4 as a first-line test because all the . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.